EMERGRAN-3

Main information

  • Trade name:
  • EMERGRAN-3 INJ INJ
  • Dosage:
  • 3MG
  • Pharmaceutical form:
  • INJ
  • Composition:
  • INJ
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EMERGRAN-3 INJ INJ
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

23-7-2018

SANCUSO (Kyowa Kirin Holdings B.V.)

SANCUSO (Kyowa Kirin Holdings B.V.)

SANCUSO (Active substance: granisetron) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)4891 of Mon, 23 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2296/T/52

Europe -DG Health and Food Safety